Back to Search
THOMAS ROTHSTEIN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1689795742Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
41316(MA)
Research & Publications (20)
Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.
PMID 19493057·J Intern Med·2009
6-review
STAT3 activation, chemokine receptor expression, and cyclin-Cdk function in B-1 cells.
PMID 11125469·Curr Top Microbiol Immunol·2000
4-observational
Receptor-specific regulation of B-cell susceptibility to Fas-mediated apoptosis and a novel Fas apoptosis inhibitory molecule.
PMID 11043772·Immunol Rev·2000
6-review
Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells.
PMID 19592097·Mol Immunol·2009
7-preclinical
Binding of LBP-1a to specific immunoglobulin switch regions in vivo correlates with specific repression of class switch recombination.
PMID 19384868·Eur J Immunol·2009
7-preclinical
Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment.
PMID 19592656·J Immunol·2009
8-other
Fas apoptosis inhibitory molecule contains a novel beta-sandwich in contact with a partially ordered domain.
PMID 19168072·J Mol Biol·2009
7-preclinical
B cell receptor crosstalk: B cells express osteopontin through the combined action of the alternate and classical BCR signaling pathways.
PMID 18952291·Mol Immunol·2009
7-preclinical
B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-kappa B activation.
PMID 17579042·J Immunol·2007
7-preclinical
Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells.
PMID 17683116·Eur J Immunol·2007
7-preclinical
PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.
PMID 17683117·Eur J Immunol·2007
7-preclinical
CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
PMID 17446175·J Biol Chem·2007
7-preclinical
Cutting Edge: B cell receptor (BCR) cross-talk: the IL-4-induced alternate pathway for BCR signaling operates in parallel with the classical pathway, is sensitive to Rottlerin, and depends on Lyn.
PMID 17404251·J Immunol·2007
7-preclinical
Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9.
PMID 18025183·J Immunol·2007
7-preclinical
Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells.
PMID 17135445·Int Immunol·2007
4-observational
B-1 cells express transgelin 2: unexpected lymphocyte expression of a smooth muscle protein identified by proteomic analysis of peritoneal B-1 cells.
PMID 16487589·Mol Immunol·2006
7-preclinical
Peritoneal B-2 cells comprise a distinct B-2 cell population with B-1b-like characteristics.
PMID 16609926·Eur J Immunol·2006
7-preclinical
Disruption of cyclin D3 blocks proliferation of normal B-1a cells, but loss of cyclin D3 is compensated by cyclin D2 in cyclin D3-deficient mice.
PMID 16818732·J Immunol·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- BOSTON MEDICAL CENTER, 650 ALBANY ST-EBR C 437
ROXBURY, MA 02118 - Phone
- (617) 638-7028
Quick Facts
- NPI
- 1689795742
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile